Kroger’s Q2 2026 Results Boosted By Digital, Pharmacy Sales
Kroger reported Q2 2026 sales of $34.6B, up from $33.9B last year. Digital sales rose 20%, and pharmacy profits increased due to generic medicine sales. Operating profit grew to $971M, while adjusted FIFO operating profit dropped to $1.07B. The company expects full-year core sales growth of 0.2-0.8% and maintains its FIFO operating profit outlook at $5.0-5.2B.
How this was made

The 30-second read
Why it matters
The earnings release provides fresh guidance that trims full‑year core sales growth, which may prompt a reassessment of valuation multiples.
Market read
Kroger's earnings and guidance are material for retail investors and may influence broader grocery sector sentiment.
What to watch
Fuel price volatility and tariff refunds boosting margins are temporary and may not sustain.
Background
Kroger reported its Q2 2026 results, highlighting digital sales growth and a modest core sales increase.
Ticker impact
Q2 2026 sales of $34.6B, operating profit $971M and trimmed full‑year core sales growth outlook to 0.2‑0.8% were disclosed.
Potential short‑term downside as investors reassess growth expectations; upside if market focuses on digital sales momentum.
Guidance cut signals weaker top‑line, but strong digital and pharmacy margins may support the stock if highlighted.
Market effects
Grocery sector may see pressure on peers with similar margin constraints; digital sales growth could benefit tech‑enabled retailers.
U.S. consumer discretionary outlook slightly weakened.
Limited to U.S. grocery and retail investors.
Counterpoint
Digital sales surge could outweigh modest core growth, suggesting the stock may be undervalued.
Key entities
- ExecutiveGregory S. Foran
CEO of Kroger who commented on store expansion strategy.




